Radiosurgi tumor non-invasi pikeun kanker paru

Bagikeun Post Ieu

Pupusna patali kanker di Amérika Serikat

The American Cancer Society medalkeun laporan statistik kanker taunan 2015 na online dina 5 Januari 2015. Tingkat maotna kanker di Amérika Serikat parantos turun ku 22% ti puncakna taun 1991 dugi ka ayeuna, anu hartosna 1.5 juta pasien kanker parantos nyingkahan maotna. . Laporan éta ogé ngaramalkeun kajadian sareng mortalitas kanker di Amérika Serikat dina 2015.

kanker paru, rectal cancer, prostate cancer, and breast cancer are the most common cancer deaths, accounting for almost half of the total cancer mortality, and lung cancer accounts for 27%. For kanker paru, the mortality rate of male patients decreased by 36% from 1991 to 2011, and female patients decreased by 11%. Breast cancer mortality has declined by 35% from the peak to date, while kanker prostat and rectal cancer have decreased by 47%.

EDGE radiosurgery panyabutan tumor anu non-invasi

Dr. Liao of the Henry Ford Hospital of the United States said that because American hospitals have the world’s most advanced technology and the most experts, the United States has been at the forefront of cancer treatment in the world. The introduction and use of the EDGE non-invasive tumor removal system has further improved the level of cancer treatment in the United States. And the five-year survival rate of cancer patients. The American Henry Ford Hospital Cancer Center is an American hospital with a team of 12 oncologists. Multidisciplinary experts work together to develop a personalized treatment plan for a patient to ensure that the treatment plan is comprehensive and effective.

The EDGE tumor non-invasive radiosurgery treatment system is a cancer treatment system approved by the US FDA in 2014. It is by far the most effective tumor radiosurgery system. It is difficult to perform routine surgery on tumors such as head tumors, lung cancer, spinal tumors, kanker haté and other solid tumors. It has a treatment effect that is difficult to achieve with conventional surgery and radiotherapy equipment, and is the best choice for cancer patients to remove tumor lesions so far.

Dibandingkeun sareng bedah konvensional sareng kémoterapi konvensional, sistem panyabutan bedah non-invasif tumor EDGE ngagaduhan kaunggulan ieu:

1. Non-invasif: tanpa incision, sabar teu kudu ngalaman trauma badag bedah;

2. Waktu perlakuan pondok: ngeunaan 10 menit unggal waktu perlakuan, teu mangaruhan kualitas hirup sabar urang;

3. Kurang perlakuan kali: 1-5 kali, sakali sapoé, tanpa rumah sakit;

4. efisiensi High: Nepi ka 5 tumor bisa dihapus dina waktos anu sareng, sarta tumor nu bisa dihapus nepi ka 5-175px, nu cocog pikeun ngaleupaskeun lesions ampir sakabéh penderita tumor padet;

5. Tuntas: lagu jeung konci tumor lolos jeung mupus eta unggal 10 milliseconds, lengkep ngaleungitkeun sél tumor;

6. High-inténsitas perlakuan precision: tinggi-énergi, 0.2-milimeter-tingkat precision eliminates sél tumor, sarta ampir euweuh ruksakna sabudeureun organ penting jeung jaringan;

7. genah: euweuh anesthesia tur euweuh rumah sakit;

8. Aya ampir euweuh efek samping: sabar teu boga efek samping tina bedah rutin sarta radiotherapy.

Babandingan EDGE sareng péso gamma sareng péso gelombang:

  1. Inténsitas perlakuan anu langkung luhur: Inténsitas perlakuan radiasi EDGE langkung ti 6 kali tina péso gamma sareng péso gelombang, ngaleungitkeun sél tumor langkung tuntas.

  2. Pangaruh perlakuan leuwih hade: 0.2 mm precision, dinamis jeung real-time tracking sél tumor, pangaruh perlakuan jauh leuwih hade tinimbang péso gamma jeung péso gelombang.

  3. Langkung fokus tumor tiasa dipiceun sakaligus: EDGE tiasa ngahapus dugi ka 5 fokus tumor dina hiji waktos, sareng efisiensi perawatan langkung luhur, sedengkeun péso gamma sareng péso gelombang ngan ukur tiasa ngaleungitkeun hiji fokus tumor dina hiji waktos.

  4. Waktos anu langkung pondok: Reseksi EDGE tina sababaraha metastase otak ngan ukur 10 menit, sedengkeun pangobatan radiasi sanésna sapertos péso gamma atanapi péso gelombang nyandak 1 dugi ka 5 jam.

  5. EDGE, ampir henteu aya efek samping tina péso gamma sareng péso gelombang.

Ngalanggan Pikeun Newsletter kami

Meunang apdet sarta pernah sono blog ti Cancerfax

Langkung Kanggo Ngajalajah

Terapi Sél CAR T Berbasis Manusa: Terobosan sareng Tantangan
Terapi T-Cell mobil

Terapi Sél CAR T Berbasis Manusa: Terobosan sareng Tantangan

Terapi CAR T-sél basis manusa revolutionizes pengobatan kanker ku genetik modifying sél imun hiji sabar urang sorangan pikeun sasaran sarta ngancurkeun sél kanker. Ku ngamangpaatkeun kakuatan sistem imun awak, terapi ieu nawiskeun pangobatan anu kuat sareng pribadi sareng poténsial pikeun remisi anu berkepanjangan dina sababaraha jinis kanker.

Ngartos Sindrom Pelepasan Sitokin: Nyababkeun, Gejala, sareng Pangobatan
Terapi T-Cell mobil

Ngartos Sindrom Pelepasan Sitokin: Nyababkeun, Gejala, sareng Pangobatan

Cytokine Release Syndrome (CRS) mangrupikeun réaksi sistem imun anu sering dipicu ku sababaraha pangobatan sapertos immunotherapy atanapi terapi sél CAR-T. Éta ngalibatkeun sékrési sitokin anu kaleuleuwihan, nyababkeun gejala mimitian ti muriang sareng kacapean dugi ka komplikasi anu ngancam kahirupan sapertos karusakan organ. Manajemén butuh strategi ngawaskeun sareng intervensi anu ati-ati.

Peryogi bantosan? Tim kami siap ngabantosan anjeun.

Kami ngarepkeun pamulihan gancang tina anu anjeun sayogi sareng anu caket.

Mimitian obrolan
Kami Online! Ngobrol Jeung Kami!
Scan kode na
Halo,

Wilujeng sumping di CancerFax!

CancerFax mangrupikeun platform pioneering anu didedikasikeun pikeun ngahubungkeun individu anu nyanghareupan kanker tahap lanjut kalayan terapi sél anu inovatif sapertos terapi CAR T-Cell, terapi TIL, sareng uji klinis di sakuliah dunya.

Hayu urang nyaho naon bisa urang pigawé pikeun anjeun.

1) Pangobatan kanker di luar negeri?
2) Terapi T-Sél mobil
3) Vaksin kanker
4) Konsultasi video online
5) Terapi proton